FATE
Fate Therapeutics Inc
Price:  
3.07 
USD
Volume:  
1,720,242.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FATE Fair Value

-351.31 %
Upside

As of 2024-10-09, the Fair Value of Fate Therapeutics Inc (FATE) is -7.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.07 USD, the upside of Fate Therapeutics Inc is -351.31%.

Note: valuation result may not be accurate due to the company's negative EPS.

3.07 USD
Stock Price
-7.72 USD
Fair Price
FAIR VALUE CALCULATION

FATE Fair Value

Peter Lynch's formula is:

FATE Fair Value
= Earnings Growth Rate x TTM EPS
FATE Fair Value
= 5.00 x -1.54
FATE Fair Value
= -7.72

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -98.15 -173.39 -212.15 -281.72 -160.93 -185.27
YoY growth -47.37% -76.66% -22.35% -32.79% 42.88% -27.26%

FATE Fair Value - Key Data

Market Cap (mil) 349.61
P/E
Forward P/E
EPS -1.54
Avg earnings growth rate -27.26%
TTM earnings -175.72